An anti-phosphoinositide-specific monoclonal antibody that neutralizes HIV-1 infection of human monocyte-derived macrophages

Virology

Volumn 430, Issue 2, 2012, Pages 110-119

  Jobe, Ousman ^a,b   Peachman, Kristina K ^a,b   Matyas, Gary R ^a   Asher, Ludmila V ^a,b   Alving, Carl R ^a   Rao, Mangala ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

Chemokines; Human immunodeficiency virus; Liposomes; Macrophage; Monoclonal antibody; Neutralization; P24; Phosphoinositide

Indexed keywords

BETA CHEMOKINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY WR321; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; MOLECULAR MECHANICS; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; VIRUS RELEASE;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; CELL MEMBRANE; HIV-1; HUMANS; MACROPHAGES; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHATIDYLINOSITOL PHOSPHATES; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 84862237147     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.04.017     Document Type: Article

References (32)

1. Alam S.M., Morelli M., Dennison S.M., Liao H.X., Zhang R., Xia S.M., Rits-Volloch S., Sun L., Harrison S.C., Haynes B.F., Chen B. Role of HIV membrane in neutralization by two broadly neutralizing antibodies. Proc. Nat. Acad. Sci. U. S.A. 2009, 106:20234-20239.
2. Alving B.M., Banerji B., Fogler W.E., Alving C.R. Lupus anticoagulant activities of murine monoclonal antibodies to liposomal phosphatidylinositol phosphate. Clin. Exp. Immunol. 1987, 69:403-408.
3. Alving C.R., Beck Z., Karasavva N., Matyas G.R., Rao M. HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies. Mol. Membr. Biol. 2006, 23:453-465.
4. Beck Z., Karasavvas N., Matyas G.R., Alving C.R. Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes. J. Drug. Target 2008, 16:535-542.
5. Brown B.K., Karasavvas N., Beck Z., Matyas G.R., Birx D.L., Polonis V.R., Alving C.R. Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: Role of phosphate-binding subsites. J. Virol. 2007, 81:2087-2091.
6. Brugger B., Glass B., Haberkant P., Leibrecht I., Wieland F.T., Krausslich H.G. The HIV lipidome: A raft with an unusual composition. Proc. Nat. Acad. Sci. U.S.A. 2006, 103:2641-2646.
7. Cantin R., Diou J., Belanger D., Tremblay A.M., Gilbert C. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J. Immunol. Methods 2008, 338:21-30.
8. Carter C.A., Ehrlich L.S. Cell biology of HIV-1 infection of macrophages. Annu. Rev. Microbiol. 2008, 62:425-443.
9. Carter G.C., Bernstone L., Sangani D., Bee J.W., Harder T., James W. HIV entry in macrophages is dependent on intact lipid rafts. Virology 2009, 386:192-202.
10. Chan R., Uchil P.D., Jin J., Shui G., Ott D.E., Mothes W., Wenk M.R. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J. Virol. 2008, 82:11228-11238.
11. Deneka M., Pelchen-Matthews A., Byland R., Ruiz-Mateos E., Marsh M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell Biol. 2007, 177:329-341.
12. Di Paolo G., De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006, 443:651-657.
13. Eisert V., Kreutz M., Becker K., Konigs C., Alex U., Rubsamen-Waigmann H., Andreesen R., von Briesen H. Analysis of cellular factors influencing the replication of human immunodeficiency virus type I in human macrophages derived from blood of different healthy donors. Virology 2001, 286:31-44.
14. Haynes B.F., Fleming J., Clair E.W., Katinger H., Stiegler G., Kunert R., Robinson J., Scearce R.M., Plonk K., Staats H.F., Ortel T.L., Liao H.X., Alam S.M. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 2005, 308:1906-1908.
15. Holl V., Hemmerter S., Burrer R., Schmidt S., Bohbot A., Aubertin A.M., Moog C. Involvement of Fc gamma RI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages. J. Immunol. 2004, 173:6274-6283.
16. Karasavvas N., Beck Z., Tong J., Matyas G.R., Rao M., McCutchan F.E., Michael N.L., Alving C.R. Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes. Biochem. Biophys. Res. Commun. 2008, 366:982-987.
17. Marechal V., Prevost M.C., Petit C., Perret E., Heard J.M., Schwartz O. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J. Virol. 2001, 75:11166-11177.
18. Matyas G.R., Beck Z., Karasavvas N., Alving C.R. Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1. Biochim. Biophys. Acta 2009, 1788:660-665.
19. Matyas G.R., Wieczorek L., Bansal D., Chenine A.L., Sanders-Buell E., Tovanabutra S., Kim J.H., Polonis V., Alving C.R. Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of beta-chemokines. Biochem. Biophys. Res. Commun. 2010, 402:808-812.
20. Matyas G.R., Wieczorek L., Beck Z., Ochsenbauer-Jambor C., Kappes J.C., Michael N.L., Polonis V.R., Alving C.R. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes. AIDS 2009, 23:2069-2077.
21. Mentzer S.J., Guyre P.M., Burakoff S.J., Faller D.V. Spontaneous aggregation as a mechanism for human monocyte purification. Cell. Immunol. 1986, 101:312-319.
22. Miyauchi K., Kim Y., Latinovic O., Morozov V., Melikyan G.B. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009, 137:433-444.
23. Montero M., van Houten N.E., Wang X., Scott J.K. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol. Mol. Biol. Rev. 2008, 72:54-84.
24. Moody M.A., Liao H.X., Alam S.M., Scearce R.M., Plonk M.K., Kozink D.M., Drinker M.S., Zhang R., Xia S.M., Sutherland L.L., Tomaras G.D., Giles I.P., Kappes J.C., Ochsenbauer-Jambor C., Edmonds T.G., Soares M., Barbero G., Forthal D.N., Landucci G., Chang C., King S.W., Kavlie A., Denny T.N., Hwang K.K., Chen P.P., Thorpe P.E., Montefiori D.C., Haynes B.F. Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines. J. Exp. Med. 2010, 207:763-776.
25. Moody M.A.P.M., Fuller L., Liao H., Xia S., Drinker M.S., et al. Antilipid human monoclonal antibodies inhibit HIV-1 infection of PBMC by binding to host cells. AIDS Res. Hum. Retroviruses 2008, 24(Suppl 1):13.
26. Nguyen D.H., Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 2000, 74:3264-3272.
27. Ono A., Ablan S.D., Lockett S.J., Nagashima K., Freed E.O. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Nat. Acad. Sci. U.S.A. 2004, 101:14889-14894.
28. Phogat S., Svehla K., Tang M., Spadaccini A., Muller J., Mascola J., Berkower I., Wyatt R. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles. Virology 2008, 373:72-84.
29. Sanchez-Martinez S., Lorizate M., Hermann K., Kunert R., Basanez G., Nieva J.L. Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody. FEBS Lett. 2006, 580:2395-2399.
30. Trubey C.M., Chertova E., Coren L.V., Hilburn J.M., Hixson C.V., Nagashima K., Lifson J.D., Ott D.E. Quantitation of HLA class II protein incorporated into human immunodeficiency type 1 virions purified by anti-CD45 immunoaffinity depletion of microvesicles. J. Virol. 2003, 77:12699-12709.
31. Wassef N.M., Roerdink F., Swartz G.M., Lyon J.A., Berson B.J., Alving C.R. Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes. Mol. Immunol. 1984, 21:863-868.
32. Welsch S., Keppler O.T., Habermann A., Allespach I., Krijnse-Locker J., Krausslich H.G. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 2007, 3:e36.